Technical Analysis for MRTX - Mirati Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 114.93 -0.77% -0.89
MRTX closed down 0.77 percent on Friday, July 10, 2020, on 86 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical MRTX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
NR7 Range Contraction 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.77%
Outside Day Range Expansion -0.77%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.42%
Inside Day Range Contraction -3.42%
MACD Bearish Signal Line Cross Bearish -2.09%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.09%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mirati Therapeutics Inc., a biopharmaceutical company, engages in the development of therapeutics for the cancer treatment. Its lead program in clinical development is MGCD265, a multi-targeted small molecule kinase inhibitor for treatment of oncology patients with solid tumors. The company also evaluates development opportunities in oncology for mocetinostat, a spectrum-selective HDAC inhibitor for the treatment of patients with myelodysplastic syndrome or lymphoma; and MGCD516, a kinase inhibitor with a target profile for the treatment of patients with non-small cell lung cancer and other solid tumors. Mirati Therapeutics Inc. is headquartered in San Diego, California.
Medicine Biopharmaceutical Cancer Chemical Compounds Oncology Solid Tumors Non Small Cell Lung Cancer Lymphoma Cancer Treatment Targeted Therapy Myelodysplastic Syndrome Bemcentinib

Is MRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 132.59
52 Week Low 66.01
Average Volume 482,348
200-Day Moving Average 94.97
50-Day Moving Average 105.14
20-Day Moving Average 113.80
10-Day Moving Average 116.04
Average True Range 5.35
ADX 19.94
+DI 17.87
-DI 13.56
Chandelier Exit (Long, 3 ATRs ) 105.84
Chandelier Exit (Short, 3 ATRs ) 114.82
Upper Bollinger Band 123.38
Lower Bollinger Band 104.22
Percent B (%b) 0.56
BandWidth 16.83
MACD Line 3.75
MACD Signal Line 4.23
MACD Histogram -0.4865
Fundamentals Value
Market Cap 2.87 Billion
Num Shares 25 Million
EPS -3.38
Price-to-Earnings (P/E) Ratio -34.00
Price-to-Sales 0.00
Price-to-Book 3.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 120.23
Resistance 3 (R3) 120.38 118.77 119.34
Resistance 2 (R2) 118.77 117.42 118.69 119.05
Resistance 1 (R1) 116.85 116.59 116.05 116.70 118.75
Pivot Point 115.24 115.24 114.84 115.16 115.24
Support 1 (S1) 113.32 113.89 112.52 113.17 111.11
Support 2 (S2) 111.71 113.06 111.63 110.81
Support 3 (S3) 109.79 111.71 110.52
Support 4 (S4) 109.64